Human CD86 Protein, His Tag
- 
									
产品编号
KMP2357
 - 
									
别名
T 淋巴细胞活化抗原 CD86, T-lymphocyte activation antigen CD86, CD86
 - 
									
规格
- 50ug
 - 100ug
 - 200ug
 
 
| Catalog Number | KMP2357 | 
| Alias | T 淋巴细胞活化抗原 CD86, T-lymphocyte activation antigen CD86, CD86 | 
| Size | 50ug, 100ug, 200ug | 
| Product Description | The Human CD86 Protein(KMP2357) is produced in HEK293 Cells and the target gene encoding Ala24-Pro247 is expressed with a 6His tag at the C-terminus. | 
| Molecular Name | CD86 | 
| Product Introduction | CD86(B7-2):免疫球蛋白超家族跨膜蛋白,与CD80协同作用,提供T细胞活化的共刺激信号。 | 
| Molecular Weight | 26.37 kDa | 
| Expression System | HEK293 Cells | 
| Species | Human | 
| Purity | >95% | 
| SDS-PAGE | ![]()  | 
| Purification | Affinity Purification | 
| Uniprot ID | P42081 | 
| Storage Condition | Aliquot and store at -20℃ to -80℃. Avoid repeated freezing and thawing cycles. | 
| Formulation | 20mM PB, 150mM NaCl, pH7.2 | 
| Shipping Condition | In general, the proteins are provided as lyophilized powder which are shipped at ambient temperature. They are shipped out in dry ice if supplied in liquid form. | 
| Background | The protein is the receptor that involved in the costimulatory signal essential for T-lymphocyte proliferation and interleukin-2 production, by binding CD28 or CTLA-4. It may play a critical role in the early events of T-cell activation and costimulation of naive T-cells, such as deciding between immunity and anergy that is made by T-cells within 24 hours after activation. Isoform 2 interferes with the formation of CD86 clusters, and thus acts as a negative regulator of T-cell activation. The protein interacts with MARCH8, human herpesvirus 8 MIR2 protein, adenovirus subgroup B fiber proteins and acts as a receptor for these viruses.It is expressed by activated B-lymphocytes and monocytes and promoted by MARCH8 and results in endocytosis and lysosomal degradation.It contains 1 Ig-like C2-type(immunoglobulin-like) domainand 1 Ig-like V-type(immunoglobulin-like) domain. | 
| Endotoxin | <1.0 EU/ug determined by the LAL method | 
| Product Declaration | 该产品仅供科研使用,不可直接用于人体或注射。 | 
可优化表达条件(如降低诱导温度、调整IPTG浓度)、使用促溶标签(如SUMO、GST)、共表达分子伴侣,或尝试不同宿主系统(如哺乳动物细胞或昆虫细胞)以提高可溶性蛋白产量。
常用的纯化方法包括亲和层析(如His-Tag、GST-Tag)、离子交换层析、疏水相互作用层析(HIC)和凝胶过滤层析。具体方法取决于蛋白特性和标签类型。
							
							
							
							
						
								0